News

Letter Updates


Nov 15, 2024
Press Release

E&C Leaders Demand Secretary Granholm End Attempts to Hamstring President-elect Trump’s Energy Agenda

“DOE is threatening domestic jobs and economic development, weakening the energy security of European allies, and strengthening our adversaries” Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA), Energy, Climate, and Grid Security Subcommittee Chair Jeff Duncan (R-SC), and Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA) sent a letter to Department of Energy (DOE) Secretary Jennifer Granholm demanding the agency stop rushing to prematurely release its anti-liquefied natural gas (LNG) study, which aims to hamstring the incoming Presidential administration. The letter also calls for DOE to lift the pause on LNG exports, which was a politically motivated decision by the Biden administration to appease radical environmental activists at the expense of American energy security and the security of our allies. KEY LETTER EXCERPTS: “Despite DOE’s prior findings and published reviews in favor of U.S. LNG exports, and contrary to DOE’s limited statutory authority under the NGA, the Biden administration’s DOE announced that it would expand its environmental review as part of a ‘managed transition’ to reduce use of fossil fuels. Recent press reports indicate that DOE is racing to complete a study on the climate impacts of LNG exports to hamper the incoming Republican administration and provide opportunities to challenge future project approvals in court.” [...] “ The results of the 2024 presidential election are clear, and DOE leadership will soon change. As a traditional part of the peaceful transfer of power, DOE should immediately stop work on any plans to expand the scope of review or add new conditions to LNG export licenses. DOE should immediately lift the ban on LNG export approvals in compliance with the NGA and the District Court order.” BACKGROUND: January 26, 2024 : The Biden administration announces indefinite “pause” on LNG export permits. Chair Rodgers immediately rebukes the decision, calling it a “gift to Putin.” February 5, 2024 : More than 150 House Republicans demand President Biden ends his de facto ban on American LNG exports. February 15, 2024 : E&C Republicans lead bipartisan passage of H.R. 7176 to reverse President Biden’s LNG export ban. April 8, 2024 : The Subcommittee on Energy, Climate, and Grid Security holds a field hearing in Port Arthur, Texas, with local leaders and energy workers to highlight the economic and public benefits of American energy production, including job creation. November 7, 2024 : Bloomberg Law reports that the “Biden administration is racing to complete a study that could complicate President-Elect Donald Trump’s plan to immediately approve new liquefied natural gas export terminals.” CLICK HERE to read the full letter.



Nov 12, 2024
Press Release

E&C Republicans Ask GAO to Assess Structure of CDC, FDA, and NIH Lab Safety Offices

Washington, D.C. — In a new letter to Government Accountability Office Comptroller General Gene Dodaro, House Energy and Commerce Committee Republicans have requested an examination of the structure of laboratory safety programs at the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH).  The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA).  KEY LETTER EXCERPT :  This committee remains concerned about the effectiveness of the oversight HHS and its agencies provide to the laboratories they own and operate. In addition to numerous GAO recommendations that remain unimplemented by the FDA, both the CDC and the FDA recently announced organizational reforms to their laboratory safety and security functions, and it is not clear whether these changes will strengthen oversight or create new undue risk. The FDA has, for example, reorganized several of its laboratories such that they now fall within the Office of the Chief Scientist. This raises potential independence concerns, as the FDA’s laboratory safety and security functions report to the same office.  BACKGROUND :  The mission of the U.S. Department of Health and Human Services (HHS) is to enhance the health and well-being of all Americans.   As such, HHS is most directly involved in leading public health preparedness and response efforts, as well as associated research.   However, past safety lapses involving the CDC, the FDA, and the NIH have been the result of multiple breakdowns in compliance with established policies coupled with inadequate oversight.   For example, in July 2014, boxes containing decades-old vials of smallpox and other hazardous biological agents were found in a storage space of an FDA laboratory on the NIH’s campus. GAO and other reviews resulted in numerous findings and recommendations to strengthen laboratory safety and security, which led to changes to the way HHS and its agencies oversee their laboratories.   Likewise, GAO and other reviews have highlighted the importance of laboratory science and security in the handling of federal select agents and other dangerous pathogens in research.  CLICK HERE to read the full letter.



Nov 6, 2024
Press Release

Chair Rodgers to Federal Agencies: No More Partisan Work

Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) today sent letters to five independent federal agencies urging the Biden-Harris administration appointees to abandon partisan efforts and instead focus remaining efforts on bipartisan, consensus items.   The letters state, “The results of the 2024 presidential election are now apparent and leadership of the [agency] will soon change. As a traditional part of the peaceful transfer of power, the [agency] should immediately stop work on any partisan or controversial item under consideration, consistent with applicable law and regulation.”    Click below to read each agency’s letter:   Consumer Product Safety Commission (CPSC) Federal Communications Commission (FCC)   Federal Trade Commission (FTC)   Federal Energy Regulatory Commission (FERC)   Nuclear Regulatory Commission (NRC) Note: In the letter, Chair Rodgers urges NRC to continue timely implementation of the ADVANCE Act. 



Oct 21, 2024
Press Release

Bipartisan E&C Leaders Call on GAO to Review the DOE Isotope Program’s Work to Reduce Reliance on Russia

More than a decade has lapsed since the GAO’s last review Washington, D.C. —  In a new letter to the U.S. Government Accountability Office (GAO), bipartisan Energy and Commerce Leaders are requesting that the GAO conduct an extensive review of the Department of Energy’s (DOE) Isotope Program. Led by Committee Chair Cathy McMorris Rodgers (R-WA) and Ranking Member Frank Pallone, Jr., (D-NJ) as well as Subcommittee on Energy, Climate, and Grid Security Chair Jeff Duncan (R-SC) and Ranking Member Diana DeGette (D-CO), the letter addresses concerns regarding U.S. dependence on Russia for isotopes and other materials critical to American national security, advanced manufacturing, and medicine, especially following Russia’s invasion of Ukraine. KEY LETTER EXCERPT: “The DOE Isotope Program has been working for at least a decade to shore up domestic isotope development and free the United States from a position of dependence, but its progress in doing so is unclear. Current U.S. production still has not replaced our reliance on Russia and possibly other high-risk countries, and several proposed DOE facilities conceived as major contributors to the U.S. domestic supply chain remain in the design phase or, at best, under construction (chief among these is Oak Ridge’s Stable Isotope Production and Research Center, or SIPRC, which is reportedly not expected to start production until 2032). These dynamics raise serious questions and concerns about the security of the U.S. supply chain for these critical isotopes.” BACKGROUND: The DOE’s Isotope Program produces and sells hundreds of high priority isotopes that are rare—but essential—for the production of important commodities in national security, advanced manufacturing, and medicine.  The DOE is often the only, or one of very few, global producers of such isotopes, which are in short supply or represent a supply chain risk. However, the United States still relies on obtaining several materials and commercially produced isotopes from other, sometimes adversarial countries, such as Russia.  The GAO last reviewed the DOE Isotope program in 2012 and has not conducted a review since Russia invaded Ukraine in 2022.  According to a 2022 testimony by the executive director of the Council on Radionuclides and Radiopharmaceuticals, the U.S. still relies nearly exclusively on Russia to obtain 44 isotopes that are critical in industrial applications and cancer treatment.  China has also emerged as a new global supplier of stable isotopes, positioning the U.S. for even further foreign reliance to keep Americans healthy and safe. CLICK HERE to read the full letter.



Oct 8, 2024
Press Release

Bipartisan E&C Leaders Request FDA Briefing for More Details about Counterfeit Ozempic

Washington, D.C. — In a letter today to Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., a bipartisan group of House Energy and Commerce Committee Leaders requested a briefing about the presence of counterfeit Ozempic and other semaglutide products in the United States’ medical supply chain.  The letter was signed by Chair Cathy McMorris Rodgers (R-WA) and Ranking Member Frank Pallone, Jr. (D-NJ); Subcommittee on Health Chair Brett Guthrie (R-KY) and Ranking Member Anna G. Eshoo (D-CA); and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) and Ranking Member Kathy Castor (D-FL).   KEY LETTER QUOTE : “In addition to concerns about integrity gaps in the legitimate supply chain, we are also concerned about counterfeit Ozempic entering through illegal channels. For example, in June of this year, Eli Lilly issued an open letter expressing concern that counterfeit versions of its own drugs, Mounjaro and Zepbound, were being sold online, through social media and at medical spas. On May 1, 2024, a Department of Justice press release reported that work by FDA’s Office of Criminal Investigations resulted in the arrest of an individual for selling misbranded and adulterated weight loss drugs on TikTok. The Committee fully supports these continued investigations of unlawful sales.”   BACKGROUND :   The FDA alerted the public on December 21, 2023, to the presence of counterfeit Ozempic injection products in the legitimate drug supply; an investigati ve article l ater found that thousands of counterfeit Ozempic pens had arrived in a warehouse in Elmira, New York, as early as the fall of 2023. The fact that counterfeit medications made it into the legitimate medical supply chain raises concern about potential gaps in our supply chain security infrastructure.    This threat continues to grow.   CLICK HERE to read the full letter.



Oct 7, 2024
Letter

Chair Rodgers Leads House GOP in Demanding Answers Over FCC Fast-Tracking Democrat Mega-Donor’s Media Takeover Weeks Before Election

Soros-linked fund to acquire more than 200 local radio stations weeks before election Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) led 40 of her Republican colleagues in demanding answers from the Chairwoman of the Federal Communications Commission (FCC) regarding her recent decision to fast-track a media deal allowing the Fund for Policy Reform, a group aligned with Democratic mega-donor George Soros, to buy over 200 radio stations just weeks before the 2024 election. With a party line vote of 3-2, the decision at the Commission level by the Democratic members of the FCC to temporarily waive the required national security review and allow excessive foreign ownership of American radio stations is deeply disturbing. KEY LETTER EXCERPT: “It is highly concerning that the FCC did not follow regular order for a transaction of this magnitude. Licensees and investors need certainty that the FCC will follow its rules and procedures when approving transactions so that the broadcast industry can have the resources it needs to continue serving the public.”  BACKGROUND: Audacy, Inc., a radio broadcasting group, which owns more than 200 radio-station licenses, filed for bankruptcy earlier this year.  Audacy’s filings revealed that a George Soros-backed group known as the Fund for Policy Reform had acquired at least 40 percent of Audacy’s debt.   Audacy estimated that, upon emerging from bankruptcy, 25 percent or more of its stock would be indirectly foreign owned, which triggers FCC review.   This review process requires national security agencies to review the transaction and offer any policy or national security concerns.   On September 30, 2024, the FCC released an Order granting a temporary waiver of this review process, delaying a national security review until after the bankruptcy process is complete and allowing foreign control of a significant number of radio stations across the entire United States, weeks before a national election. CLICK HERE to read Breitbart's exclusive coverage. CLICK HERE to read the full letter.



Oct 2, 2024
Press Release

E&C, E&W Republicans Press ARPA-H to Uphold Civil Rights Laws in its Research Funding Process

Washington, D.C — In a new letter to Advanced Research Projects Agency for Health (ARPA-H) Director Renee Wegrzyn, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) request information on how ARPA-H is ensuring that institutions and individuals involved in the research projects it funds comply with Title VI to ensure a harassment and discrimination-free environment.  This letter comes after a rise in antisemitism on college and university campuses, including Columbia University and the University of California, San Francisco where ARPA-H currently funds research. It is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT).  KEY EXCERPT :  “Due to ongoing reports of antisemitism across colleges and universities, federal and congressional investigations into potential civil rights violations at these institutions, and an ongoing congressional investigation into HHS’s and NIH’s handling of these concerns at HHS-funded institutions, the Committees are seeking more information about how ARPA-H ensures that those involved in projects it funds comply with Title VI and relevant civil rights laws to ensure a research environment free of harassment and discrimination, especially towards those of Jewish faith and heritage.”  BACKGROUND :  ARPA-H is an independent agency of the U.S. Department of Health and Human Services (HHS) within the National Institutes of Health (NIH).  ARPA-H reports directly to the Secretary of HHS.  In the last year, ARPA-H has funded more than $595 million in research projects through ISOs and BAA with more than $506 million going to universities and research institutions and the rest to companies or organizations. Some of these research projects include:  August 30, 2024: Up to $39.5 million to Columbia University   August 22, 2024: Up to $7 million to the University of Pennsylvania   August 13, 2024: Up to $18.4 million to the University of Illinois Urbana-Champaign  July 10, 2024: Up to $27 million to the Wyss Institute at Harvard University  June 12, 2024: Up to $24 million to Yale University School of Medicine  April 1, 2024: Up to $35 million to the University of California, San Francisco  September 26, 2023: Up to $104 million to Harvard Medical School  September 25, 2023: Up to $26 million to Stanford University  Of the fourteen university-based projects ARPA-H funded in the last year, eleven (including the eight listed above) are at universities that were recently or are currently under federal and/or congressional investigation for potential Title VI violations and/or are being sued in federal court for permitting antisemitic behavior on campus.  Columbia University has been sued in federal court, is currently undergoing several investigations by the U.S. Department of Education Office for Civil Rights, and is undergoing investigation by congressional committees, for complaints of antisemitism.  The Committee on Energy and Commerce is currently investigating the University of California, San Francisco regarding concerns of antisemitism at the university, medical school, and associated medical centers.  The U.S. Department of Education recently closed its investigation into the University of Illinois-Urbana Champaign with a resolution agreement that found the university was not meeting its obligation under Title VI as it relates to complaints of shared ancestry discrimination—including 135 complaints of anti-Jewish discrimination.  CLICK HERE to read the full letter.



Sep 19, 2024
Press Release

E&C, E&W Republicans Demand Answers from Columbia University

Letter comes following allegation student was delayed care due to Israeli heritage Washington, D.C. — In a new letter to Columbia University Interim President Katrina Armstrong, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) are demanding answers regarding ongoing and pervasive acts of antisemitic harassment and intimidation at the University and its associated medical school and centers. The letter, signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT) requests that Columbia University respond to the Committees’ questions by no later than October 2, 2024.  It is part of Speaker Mike Johnson’s (R-LA) House-wide  effort  to crack down on antisemitism on college campuses.  KEY EXCERPTS : “A report from the Columbia University Antisemitism Task Force highlighted how the hostility on Columbia University campuses had spilled over into the medical center and medical services as well. For example, an Israeli student reported that when she went to health services in July 2024, no one came into the room to see her, and she overheard a discussion between two health care professionals in another room in which one said they would not treat her because she was Israeli. She sat in the room for another ten minutes until someone finally came to address her health needs.”  [...]  “Failing to comply with basic safety protections for members of the Columbia University community and to respond appropriately to and prevent harassment and discrimination, no matter the cause, may be grounds to withhold federal funds from the university and its associated medical centers. Congress has an obligation to ensure compliance with Title VI. If Congress determines an institution of higher education is in violation, it may consider rescinding research and development funds previously appropriated. Similarly, if Congress determines a medical facility is in violation, it may consider rescinding the right to participate in federal health care programs.”  CLICK HERE to read the full letter.  BACKGROUND :  Beginning on April 17, 2024, an encampment sprung up on Columbia University’s campus with hundreds of protestors and tents.  Banners and signs vandalized the campus—including residence halls—with antisemitic sentiments and even support for the terrorist organization Hamas.  Chants and statements by those within the encampment also supported messages of violence and hate towards Jewish students, with a leader of the encampment filmed stating that, “Zionists don’t deserve to live.”  Professors at Columbia University have also openly made antisemitic and pro-Hamas statements—including more than 100 professors signing a letter in support of the October 7, 2023, terrorist attack by Hamas—adding to the harassment of Jewish students.  An English professor held his classes inside the encampment, despite the fact that it was an uncomfortable and unsafe environment for some of the students in the class, who did not attend.  A prominent rabbi at Columbia University warned Jewish students to remain off-campus during the end of the academic year in Spring 2024 due to fears that the university and New York City police could not keep students safe.  Jewish students on campus also expressed concerns over their safety on campus and the mental and psychological toll the hostile environment was taking on their ability to work and learn. Despite over 100 arrests, the protests progressed to the occupation of a campus building and physical attacks of Jewish students, leading campus officials to move some classes online for the remainder of the academic year.  Columbia University also has a medical school, as well as several affiliated medical centers. Antisemitism has no place in an institution where students go to learn how to be the next generation of medical professionals caring for patients of all religions and ethnic backgrounds.  An interview with students at Irving Medical Center, where Columbia University’s medical school is housed, emphasized the extent to which Jewish students felt excluded and unable to openly identify as Jewish or express their Jewish identity on campus.  A nursing student, for example, stated that the sheer number of antisemitic policy violations that are minimized and go unpunished have made the behavior a norm and that the “Columbia nursing [school] is not a place for Jews.”



Sep 19, 2024
Press Release

E&C, E&W Republicans Issue Document Request to Secretary Becerra After HHS Dodges Questions on Protecting Students from Antisemitism on Campus

Washington, D.C. — In a new letter to Department of Health and Human Services (HHS) Secretary Xavier Becerra, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) issued a request for documentation related to the Committees’ ongoing investigation into how the department is preventing and responding to antisemitism at grantee institutions. The letter follows up on a May 23, 2024, letter to which HHS failed to respond to adequately and is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT). KEY EXCERPT :  “Responding on your behalf in an August 22, 2024, letter, the HHS Assistant Secretary for Legislation stated that, “The HHS Office for Civil Right (OCR) enforces federal civil rights laws prohibiting various forms of discrimination in HHS-funded programs and activities […]” and that “OCR takes this duty seriously.” Despite this declaration, the lacking response from HHS failed to provide specific information about how HHS OCR or the NIH have taken steps to ensure that institutions and universities receiving funding from HHS are complying with federal civil rights laws amongst these extensively reported acts of antisemitism, and whether HHS OCR or the NIH have received any complaints regarding potential violations of federal law as it pertains to antisemitism.” The Chairs requested the following documents by no later than October 2, 2024: A list of all misconduct allegations at NIH-funded institutions relating to alleged antisemitic incidents from fiscal year 2023 to present received by HHS OCR and/or the NIH, showing:   the date;   which agency received the allegation;   a brief description of the incident;   role of the alleged perpetrator and victim (e.g., student or faculty) with their names redacted;  institution;   entity responsible for reviewing the case (including whether the complaint is an official Title VI case);   case status;   actions taken by the institution; and   actions taken by HHS/NIH.  All documents and communications, including but not limited to, text messages, emails, and electronic messages, to or from HHS OCR/to or from the NIH referring or related to misconduct allegations or concerns over actions at NIH-funded institutions from fiscal year 2023 to present, referring or relating to, alleged antisemitic incidents; targeting of Jews, Israelis, Zionists, or Zionism; university encampments; and/or the Israeli-Palestinian conflict.  All documents and communication between HHS OCR and other agencies regarding assistance with Title VI compliance, particularly related to antisemitism (shared ancestry).  All documents and communication between HHS OCR and NIH-funded institutions related to Title VI compliance reviews related to antisemitism (shared ancestry).    From fiscal year 2023 to present, all documents, communications, and guidance provided from HHS OCR and the NIH to grantee institutions and individuals at grantee institutions regarding Title VI responsibilities and protections, including those specific to protections for those of Jewish faith and heritage, and all documents or communications regarding HHS/NIH’s stance on antisemitism, the events occurring on university campuses, and/or the Israeli-Palestinian conflict generally.  CLICK HERE to read the full letter.